Cargando…

Body mass index (BMI) does not predict responses to psilocybin

BACKGROUND: Psilocybin is a serotonin type 2A (5-HT(2A)) receptor agonist and naturally occurring psychedelic. 5-HT(2A) receptor density is known to be associated with body mass index (BMI), however, the impact of this on psilocybin therapy has not been explored. While body weight-adjusted dosing is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spriggs, Meg J, Giribaldi, Bruna, Lyons, Taylor, Rosas, Fernando E, Kärtner, Laura S, Buchborn, Tobias, Douglass, Hannah M, Roseman, Leor, Timmermann, Christopher, Erritzoe, David, Nutt, David J, Carhart-Harris, Robin L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834321/ https://www.ncbi.nlm.nih.gov/pubmed/36373934 http://dx.doi.org/10.1177/02698811221131994

Ejemplares similares

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
por: Barba, Tommaso, et al.
Publicado: (2022)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression
por: Weiss, Brandon, et al.
Publicado: (2023)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
por: Murphy, Roberta, et al.
Publicado: (2022)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
por: Roseman, Leor, et al.
Publicado: (2014)

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
por: Shukuroglou, Melissa, et al.
Publicado: (2022)

Effects of psilocybin therapy on personality structure
por: Erritzoe, D., et al.
Publicado: (2018)

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
por: Spriggs, Meg J., et al.
Publicado: (2021)

DMT Models the Near-Death Experience
por: Timmermann, Christopher, et al.
Publicado: (2018)

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
por: Kaertner, L. S., et al.
Publicado: (2021)

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research
por: Bornemann, Julia, et al.
Publicado: (2021)

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
por: Singleton, S. Parker, et al.
Publicado: (2022)

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
por: Carhart-Harris, Robin L, et al.
Publicado: (2017)

The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world
por: Watts, Rosalind, et al.
Publicado: (2022)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
por: Carhart-Harris, R. L., et al.
Publicado: (2017)

Psychedelics alter metaphysical beliefs
por: Timmermann, Christopher, et al.
Publicado: (2021)

Human brain effects of DMT assessed via EEG-fMRI
por: Timmermann, Christopher, et al.
Publicado: (2023)

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
por: Kettner, H., et al.
Publicado: (2021)

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
por: Gabay, Anthony S., et al.
Publicado: (2018)

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
por: Zeifman, Richard J., et al.
Publicado: (2023)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023)

Psychedelics and health behaviour change
por: Teixeira, Pedro J, et al.
Publicado: (2021)

Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
por: Peill, Joseph M, et al.
Publicado: (2022)

Neural correlates of the DMT experience assessed with multivariate EEG
por: Timmermann, Christopher, et al.
Publicado: (2019)

Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience
por: Singleton, S. Parker, et al.
Publicado: (2023)

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021)

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
por: Stroud, J. B., et al.
Publicado: (2017)

Predicting Responses to Psychedelics: A Prospective Study
por: Haijen, Eline C. H. M., et al.
Publicado: (2018)

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
por: Forstmann, Matthias, et al.
Publicado: (2023)

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
por: Schartner, Michael M., et al.
Publicado: (2017)

Psychedelic therapy in the treatment of addiction: the past, present and future
por: Zafar, Rayyan, et al.
Publicado: (2023)

Psychedelics, Meditation, and Self-Consciousness
por: Millière, Raphaël, et al.
Publicado: (2018)

The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression
por: Buchborn, Tobias, et al.
Publicado: (2023)

LSD alters dynamic integration and segregation in the human brain
por: Luppi, Andrea I., et al.
Publicado: (2021)

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD
por: Atasoy, Selen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5qo30qbtk79o5u26mvc94ilj5a